Yutian Capsule and KY Polysaccharide have been developed for the treatment of lung disease and lung cancer. Both these products have been approved by the Guangzhou Technology Bureau. The Company has successfully shown the chemical structure as well as the molecular weight of the compounds in these two drugs. This is a breakthrough for Traditional Chinese Medicine (“TCM”) research as TCM has entered a new era of molecular level research.

Aflatoxin-Detoxifizyme (“ADTZ”) project has been accepted by the High-Tech National Natural Science Foundation of China as a part of the China’s National “863 Plan.” ADTZ, an enzyme that can eliminate aflatoxin from food and animal feed. Aflatoxin, a toxic substance that causes liver, stomach and lung cancers in animals and humans, is produced by the common aspergillus fungus and frequently affects cereal grains, oilseeds, spices and tree nuts.  China Medicine will launch its trial sales in 2008.